Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy

Europace

Volumn 15, Issue 1, 2013, Pages 116-121

  Ptaszynski, Pawel ^a   Kaczmarek, Krzysztof ^a   Ruta, Jan ^a   Klingenheben, Thomas ^b   Wranicz, Jerzy K ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Cardiology Practice Bonn   (Germany)

Author keywords

Heart rate; Inappropriate sinus tachycardia; Ivabradine; Metoprolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IVABRADINE; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; NADOLOL; RAMIPRIL; VERAPAMIL;

ADULT; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FOLLOW UP; HEART PALPITATION; HEART RATE; HOLTER MONITORING; HUMAN; HYPERTENSION; HYPOTENSION; INAPPROPRIATE SINUS TACHYCARDIA; MALE; PRESYNCOPE; PRIORITY JOURNAL; SINUS TACHYCARDIA; SYMPTOM; THORAX PAIN; TREADMILL EXERCISE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTI-ARRHYTHMIA AGENTS; BENZAZEPINES; FEMALE; HUMANS; MALE; METOPROLOL; TACHYCARDIA, SINUS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84871224378     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus204     Document Type: Article

References (31)

1. Bauernfeind R, Amat-Y-Leon F, Dhingra RC, Kehoe R, Wyndham C, Rosen KM. Chronic nonparoxysmal sinus tachycardia in otherwise healthy persons. Ann Intern Med 1979;91:702-10 (Pubitemid 10218040)
2. Cossu SF, Steinberg JS. Supraventricular tachyarrhythmias involving the sinus node: Clinical and electrophysiologic characteristics. Prog Cardiovasc Dis 1998;41: 51-63 (Pubitemid 28385249)
3. Still A-M, Raatikainen P, Ylitalo A, Kauma H, Ikäheimo M, Antero Kesäniemi Y et al. Prevalence, characteristics and natural course of inappropriate sinus tachycardia. Europace 2005;7:104-12 (Pubitemid 40347853)
4. Kalman JM. Inappropriate sinus tachycardia: An update. Cardiac Electrophysiol Rev 1999;3:115-6
5. Femeni'a F, Baranchuk A, Morillo CA. Inappropriate sinus tachycardia: Current therapeutic options. Cardiol Rev 2012;20:8-14
6. Morillo CA, Klein GJ, Thakur RK, Li H, Zardini M, Yee R. Mechanism of 'inappropriate' sinus tachycardia. Role of sympathovagal balance. Circulation 1994;90:873-7 (Pubitemid 24242757)
7. Leon H, Guzman J, Kuusela T, Dillenburg R, Kamath M, Morillo CA. Impaired baroreflex gain in patients with inappropriate sinus tachycardia. J Cardiovasc Electrophysiol 2005;16:64-8 (Pubitemid 40165454)
8. Castellanos A, Moleiro F, Chakko S, Acosta H, Huikuri H, Mitrani RD et al. Heart rate variability in inappropriate sinus tachycardia. Am J Cardiol 1998;82:531-4 (Pubitemid 28389959)
9. Lee RJ, Shinbane JS. Inappropriate sinus tachycardia. Diagnosis and treatment. Cardiol Clin 1997;15:599-605 (Pubitemid 27509599)
10. Shen W-K. Modification and ablation for inappropriate sinus tachycardia: Current status. Card Electrophysiol Rev 2002;6:349-55 (Pubitemid 36104449)
11. Lee RJ, Kalman JM, Fitzpatrick AP, Epstein LM, Fisher WG, Olgin JE et al. Radiofrequency catheter modification of the sinus node for ''inappropriate'' sinus tachycardia. Circulation 1995;92:2919-28
12. Man K, Knight B, Tse H, Pelosi F, Michaud GF, Flemming M et al. Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol 2000;35:451-7 (Pubitemid 30125537)
13. Marrouche N, Beheiry S, Tomassoni G, Cole C, Bash D, Dresing T et al. Threedimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome. J Am Coll Cardiol 2002;39: 1046-54 (Pubitemid 34234129)
14. Mason PK, DiMarco JP. New pharmacological agents for arrhythmias. Circ Arrhythm Electrophysiol 2009;2:588-97
15. Rakovec P. Treatment of inappropriate sinus tachycardia with ivabradine. Wien Klin Wochenschr 2009;121:716-8
16. Calò L, Rebecchi M, Sette A, Martino A, de Ruvo E, Sciarra L et al. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm 2010;7:1318-23
17. Kaplinsky E, Comes FP, Urondo LS, Ayma FP. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: A three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessment. Cardiol J 2010;17:166-71
18. Zellerhoff S, Hinterseer M, Felix Krull B, Schulze-Bahr E, Fabritz L, Breithardt G et al. Ivabradine in patients with inappropriate sinus tachycardia. Naunyn-Schmied Arch Pharmacol 2010;382:483-6
19. Retegui G, Quintero M, Ruiz-Borrell M, Revello A. Ivabradine as a treatment option for inappropriate sinus tachycardia. Rev Esp Cardiol 2009;62:577-9
20. Winum P-F, Cayala G, Rubini M, Beck L, Messner-Pellenc P. A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine. Pacing Clin Electrophysiol 2009;32:942-4
21. Khan S, Hamid S, Rinaldi C. Treatment of inappropriate sinus tachycardia with ivabradine in patient with postural orthostatic tachycardia syndrome and dual chamber pacemaker. Pacing Clin Electrophysiol 2009;32:131-3
22. Sette A, Martino A, Lioy E, Calò L. Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction. J Cardiovasc Electrophysiol 2010;21: 815-7
23. Celebi OO, Canbay A, Celebi S, Aydogdu S, Diker E. Inappropriate sinus tachycardia-successful treatment with ivabradine. Kardiol Pol 2010;68:935-7
24. McDonald C, Frith J, Newton JL. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace 2011;13:427-30
25. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9:1006-23 (Pubitemid 351773289)
26. Fox K, Ford I, Steg PG, Tendera M, Ferrari R, BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A randomized, double-blind, placebo-controlled trial. Lancet 2008;372:807-16
27. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A et al. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomized placebocontrolled study. Lancet 2010;376:875-85
28. Joannides R, Moore N, Iacob M, Compagnon P, Lerebours G, Menard JF et al. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Br J Clin Pharmacol 2006;61:127-37 (Pubitemid 43382606)
29. Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K, INITIATIVE Investigators. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005;26:2529-36 (Pubitemid 41677303)
30. Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Study Investigators. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: A 4-month, randomized, placebo-controlled trial. Eur Heart J 2009;30:540-8
31. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. J Am Med Assoc 2000;283:1295-302 (Pubitemid 30129796)